Gene Delivery Using Chemical Methods - Challenges in Delivery of Therapeutic Genomics and Proteomics - page 185

[33] Hashida M, Takemura S, Nishikawa M, Takakura Y. Targeted delivery of plasmid DNA
complexed with galactosylated poly(L-lysine). J Control Release 1998;53:301-10.
[34] Nishikawa M, Takemura S, Takakura Y, Hashida M. Targeted delivery of plasmid DNA
to hepatocytes in vivo: Optimization of the pharmacokinetics of plasmid DNA/galac-
tosylated poly(L-lysine) complexes by controlling their physicochemical properties.
J Pharmacol Exp Ther 1998;287:408-15.
[35] Choi YH, Liu F, Park JS, Kim SW. Lactose-poly(ethylene glycol)-grafted poly-L-lysine
as hepatoma cell-targeted gene carrier. Bioconjugate Chem 1998;9:708-18.
[36] Kim JS, Kim BI, Maruyama A, Akaike T, Kim SW. A new non-viral DNA delivery vec-
tor: the terplex system. J Control Release 1998;53:175-82.
[37] Kim JS, Maruyama A, Akaike T, Kim SW. Terplex DNA delivery system as a gene car-
rier. Pharm Res 1998;15:116-21.
[38] Havel RJ. Receptor and non-receptor mediated uptake of chylomicron remnants by the
liver. Atherosclerosis 1998;141:S1-7.
[39] Hein M, Ernst M, Moller F, Regensburger D. Gene transfer into rat heart-derived endo-
thelial cells. Eur J Cardiothorac Surg 1998;13:460-6.
[40] Sawamura T, Kume N, Aoyama T, Moriwaki H, Hoshikawa H, Aiba Y, et al. An endothe-
lial receptor for oxidized low-density lipoprotein. Nature 1997;386:73-7.
[41] Yu L, Suh H, Koh JJ, Kim SW. Systemic administration of terplex DNA system: pharma-
cokinetics and gene expression. Pharm Res 2001;18:1277-83.
[42] Affleck DG, Yu L, Bull DA, Bailey SH, Kim SW. Augmentation of myocardial transfec-
tion using terplex DNA: a novel gene delivery system. Gene Ther 2001;8:349-53.
[43] Sonawane ND, Szoka FC, Verkman AS. Chloride accumulation and swelling in
endosomes enhances DNA transfer by polyamine-DNA polyplexes. J Biol Chem
2003;278:44826-31.
[44] Garnett MC. Gene-delivery systems using cationic polymers. Crit Rev Ther Drug Carrier
Syst 1999;16:147-207.
[45] Boussif O, Lezoualc'h F, Zanta MA, Mergny MD, Scherman D, Demeneix B, et al.
A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo :
polyethylenimine. Proc Natl Acad Sci USA 1995;92:7297-301.
[46] Kopatz I, Remy JS, Behr JP. A model for non-viral gene delivery: through syndecan
adhesion molecules and powered by actin. J Gene Med 2004;6:769-76.
[47] Kichler A, Leborgne C, Coeytaux E, Danos O. Polyethylenimine-mediated gene delivery:
a mechanistic study. J Gene Med 2001;3:135-44.
[48] Godbey WT, Wu KK, Mikos AG. Size matters: molecular weight affects the efficiency of
poly (ethylenimine) as a gene delivery vehicle. J Biomed Mater Res 1999;45:268-75.
[49] Fischer D, Li Y, Ahlemeyer B, Krieglstein J, Kissel T. In vitro cytotoxicity testing of
polycations: influence of polymer structure on cell viability and hemolysis. Biomaterials
2003;24:1121-31.
[50] Neu M, Fischer D, Kissel T. Recent advances in rational gene transfer vector design
based on poly(ethylene imine) and its derivatives. J Gene Med 2005;7:992-1009.
[51] Wightman L, Kircheis R, Rossler V, Carotta S, Ruzicka R, Kursa M, et al. Different
behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo .
J Gene Med 2001;3:362-372.
[52] Boeckle S, von Gersdorff K, van der Piepen S, Culmsee C, Wagner E, Ogris M.
Purification of polyethylenimine polyplexes highlights the role of free polycations in
gene transfer. J Gene Med 2004;6:1102-11.
[53] Dash PR, Read ML, Barrett LB, Wolfert MA, Seymour LW. Factors affecting blood
clearance and in vivo distribution of polyelectrolyte complexes for gene delivery. Gene
Ther 1999;6:643-50.